Please login to the form below

Not currently logged in
Email:
Password:

Algeta execs join Targovax

Anna-Kirsti Aksnes and Tina Madsen join the firm

Norway's Targovax has added to its senior team with the appointment of two executives from Algeta.

Anna-Kirsti Aksnes joins the cancer immunotherapy specialist as VP clinical development and Tina Madsen joins as VP quality assurance.

Aksnes was most recently VP clinical research at Algeta, which was taken over by pharma giant Bayer in 2014. In her role she helped lead strategic, scientific, clinical development and medical communications for the company.

Madsen joins as VP quality assurance, joining from the position of director of product quality assurance. She has over 20 years of experience in the life sciences industry.

Commenting on the appointments, Targovax's CEO Gunnar Gardemyr said: “I am pleased to welcome Anne-Kirst and Tina to our team. We look forward to the insight and wealth of experience that they bring to Targovax.”

29th January 2015

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...

Infographics